|
| |
Articles
1-300 out of 600 article(s) next
| Title |
Author |
Type |
Date |
Words |
| Most elderly with dementia can successfully be taken off 'harmful' antipsychotic drugs. |
|
|
Mar 31, 2013 |
484 |
| Global CNS Therapeutics Industry. |
|
Industry overview |
Mar 25, 2013 |
5724 |
| Vanda Withdraws Its Marketing Authorization Application For Fanaptum(TM) In The European Union. |
|
|
Mar 14, 2013 |
699 |
| Shift in thinking encouraged on bipolar, schizophrenia. |
Otto, M. Alexander |
|
Mar 1, 2013 |
641 |
| EnVivo Pharmaceuticals Announces Initiation of Phase 3 Clinical Trial Program of EVP-6124 in Schizophrenia. |
|
Clinical report |
Feb 28, 2013 |
1105 |
| No new meds: with drug firms in retreat, the pipeline for new psychiatric medications dries up. |
Sanders, Laura |
|
Feb 23, 2013 |
2844 |
| Drugs.com Releases Q4 Sales for Top 100 U.S. Drugs. |
|
Financial report |
Feb 13, 2013 |
980 |
| United States : KY. AG inks $5.5 MILLION Seroquel settlement agreement with ASTRAZENECA. |
|
|
Feb 11, 2013 |
244 |
| BioLineRx Provides Clarification Regarding Interim Analysis of CLARITY Trial for BL-1020. |
|
Correction notice |
Feb 4, 2013 |
719 |
| How Antidepressants And Antipsychotics Cause Weight Gain. |
|
|
Jan 28, 2013 |
575 |
| Yoga may help fight major mental health disorders. |
|
|
Jan 26, 2013 |
414 |
| BioLineRx to Announce Interim Results of Phase II/III Trial for Schizophrenia Drug During Week of March 18, 2013. |
|
|
Jan 7, 2013 |
1207 |
| Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development. |
|
Abstract |
Jan 1, 2013 |
196 |
| Vanda Receives Negative Opinion from CHMP on Fanaptum(TM) for the Treatment of Schizophrenia. |
|
|
Dec 13, 2012 |
883 |
| Forest Laboratories, Inc. to Present Cariprazine Results from a Phase 3 Trial and Two Pharmacology Studies at the American College of Neuropsychopharmacology (ACNP) Annual Meeting. |
|
|
Dec 3, 2012 |
609 |
| Forest Laboratories Submits New Drug Application for Cariprazine for the Treatment of Both Schizophrenia and Manic or Mixed Episodes Associated with Bipolar I Disorder. |
|
Clinical report |
Nov 28, 2012 |
782 |
| Psychosis in AD may recur after dropping risperidone. |
Sullivan, Michele, G. |
|
Nov 1, 2012 |
327 |
| DSPE Regulatory Update: Acceptance of the European Medicines Agency Submission for an Atypical Antipsychotic Agent Lurasidone. |
|
|
Oct 25, 2012 |
670 |
| DSP and Takeda Announce the Acceptance of the European Medicines Agency Submission of an Atypical Antipsychotic Agent Lurasidone. |
|
|
Oct 25, 2012 |
937 |
| DSP and Takeda Announce the Acceptance of the European Medicines Agency Submission of an Atypical Antipsychotic Agent Lurasidone. |
|
|
Oct 25, 2012 |
950 |
| BioLineRx to Conduct Interim Analysis of Phase II/III CLARITY Clinical Trial of BL-1020 for Treatment of Schizophrenia. |
|
|
Oct 24, 2012 |
1065 |
| Texas Attorneys Launch New Resource for Corporate, Government Whistleblowers. |
|
|
Oct 22, 2012 |
565 |
| BioLineRx Announces New Analysis of EAGLE Phase IIb Study Showing a Significantly Greater Beneficial Effect of BL-1020 on Cognitive Function in Schizophrenia Patients. |
|
|
Oct 9, 2012 |
1263 |
| New steps in dementia drug search; HEALTH. |
|
|
Oct 9, 2012 |
115 |
| Research and Markets: Key Findings from Treatment Algorithms: Schizophrenia. |
|
|
Oct 5, 2012 |
290 |
| The relationship between mental health diagnosis and treatment with second-generation antipsychotics over time: a national study of U.S. Medicaid-enrolled children. |
Matone, Meredith; Localio, Russell; Huang, Yuan-Shung; dosReis, Susan; Feudtner, Chris; Rubin, David |
Report |
Oct 1, 2012 |
8125 |
| United States : FDA Approves Expansion of Dosing Window to Help Avoid Missed Doses in INVEGA SUSTENNA Updated Product Label. |
|
|
Sep 28, 2012 |
363 |
| BioLineRx Announces Publication of EAGLE Study Results Demonstrating BL-1020's Efficacy in Improving Cognitive Function in Schizophrenia Patients. |
|
Clinical report |
Sep 27, 2012 |
1204 |
| Psychology. |
|
Author abstract |
Sep 22, 2012 |
2658 |
| Ask the Medical Director. |
Das, Krista |
|
Sep 1, 2012 |
666 |
| Akathisia--rare cause of psychomotor agitation in patients with traumatic brain injury: case report and review of literature. |
Wielenga-Boiten, Janet E.; Ribbers, Gerard M. |
Case study |
Sep 1, 2012 |
3150 |
| Psychoactive properties of alpha-methyltryptamine: analysis from self reports of users. |
Wilcox, James |
Report |
Sep 1, 2012 |
1948 |
| Antipsychotic drug therapy: proceed with caution. |
Casey, Georgina |
|
Sep 1, 2012 |
4584 |
| United States : Janssen Pharmaceuticals, Inc. announces RISPERDAL consumer protection settlement with 36 states and the District of Columbia. |
|
|
Aug 31, 2012 |
450 |
| United States : JANSSEN gets accused for improperly promoting its antipsychotic drugs and will pay for it !! |
|
|
Aug 31, 2012 |
329 |
| Janssen Pharmaceuticals, Inc. announces RISPERDAL consumer protection settlement with 36 states and the District of Columbia. |
|
|
Aug 30, 2012 |
942 |
| PGXL to Provide Antipsychotic Drug Response Tests. |
|
|
Aug 29, 2012 |
484 |
| SureGene and PGXL Laboratories launch the SureGene Test for Antipsychotic and Antidepressant Response (STA2R). |
|
|
Aug 29, 2012 |
643 |
| Significant Opportunity Remains in the Unipolar Depression Market Due to the High Prevalence of Depressive Disorders as Well as Low Patient Response Rate to First-Line Antidepressants. |
|
|
Aug 28, 2012 |
647 |
| United States : ASTRAZENECA PLC. finalizes $26 million settlement with SOUTH CAROLINA. |
|
|
Aug 28, 2012 |
185 |
| New drug target for schizophrenia identified. |
|
|
Aug 14, 2012 |
461 |
| Dementia drug hopes are dashed; HEALTH. |
|
|
Aug 8, 2012 |
146 |
| Accounting for Nearly 90 Percent of Major-Market Sales in 2011, the United States Dominates the Bipolar Disorder Drug Market. |
|
|
Aug 2, 2012 |
695 |
| Antiepileptic Drugs Are the Most Commonly Prescribed Drug Class Among Newly Diagnosed Bipolar Disorder Patients in the United States. |
|
|
Aug 2, 2012 |
649 |
| Catalent Announces Commencement of Supply of Abilify[R] Orally Disintegrating Tablets to Otsuka Pharmaceutical Co., Ltd. and Extensive Investments to Its Zydis[R] Technology Capabilities in Swindon, UK. |
|
|
Jul 24, 2012 |
437 |
| Antipsychotics need to pile up: new insights explain delayed action in schizophrenia drugs. |
Sanders, Laura |
|
Jul 14, 2012 |
445 |
| Frost & Sullivan: European Bipolar Therapeutics Market Slows Down in the Short Term As Key Blockbuster Drugs Go Off Patent. |
|
Industry overview |
Jul 5, 2012 |
947 |
| Mylan Launches Generic Version of Lithobid Tablets. |
|
Disease/Disorder overview |
Jul 3, 2012 |
451 |
| Cariprazine targets acute mania in bipolar patients. |
Worcester, Sharon |
Clinical report |
Jul 1, 2012 |
686 |
| Antipsychotic drug targets cancer stem cells. |
|
|
Jul 1, 2012 |
278 |
| Research and Markets: Pharmacological and Psychosocial Treatments in Schizophrenia. |
|
|
Jun 20, 2012 |
429 |
| 'Dementia drug use can be cut by staff training'. |
|
|
Jun 16, 2012 |
278 |
| INVEGA[R] SUSTENNA[R] Three-Month Formulation of Paliperidone Palmitate Enters Phase 3 Clinical Program for Schizophrenia. |
|
Clinical report |
Jun 12, 2012 |
2147 |
| J&J To Pay $2.2 Billion To Settle Risperdal Probe - Report. |
|
|
Jun 11, 2012 |
135 |
| OCCMHA Chosen for National Research Study. |
|
|
Jun 11, 2012 |
445 |
| Depot antipsychotics boost compliance. |
Zoler, Mitchel L. |
|
Jun 1, 2012 |
980 |
| Metformin resolves amenorrhea in treated schizophrenia. |
Zoler, Mitchel L. |
Clinical report |
Jun 1, 2012 |
540 |
| Fetal exposure to antipsychotics. |
Cohen, Lee S. |
|
Jun 1, 2012 |
877 |
| Hope For Late-Stage Lung Cancer? Two-Drug Combo Activates Genes That Help Tumors Self-Destruct. |
|
|
Jun 1, 2012 |
389 |
| Patentability of chemical selection inventions; the olanzapine and escitalopram decisions. |
|
Book review |
Jun 1, 2012 |
123 |
| Nurofen pill spiker jailed for 18mnths; RECALL. |
|
|
May 29, 2012 |
144 |
| Nurofen tamperer jailed for 18 months. |
|
|
May 28, 2012 |
331 |
| Anti-psychotic drug kills cancer stem cells without side-effects: study. |
|
|
May 27, 2012 |
392 |
| pounds 2.4m cost of Nurofen swap scam; COURT. |
|
|
May 26, 2012 |
135 |
| Anti-Psychotic Drugs Found to Bust Cancer Cells. |
|
|
May 26, 2012 |
309 |
| Drug may 'tame' cancer cells. |
|
|
May 25, 2012 |
252 |
| Use of Bristol-Myers Squibb's Oral Abilify is Shifting to First-Line Treatment of Newly Diagnosed Schizophrenia Patients. |
|
|
May 9, 2012 |
506 |
| Forest Laboratories, Inc. to Present Cariprazine and Levomilnacipran Results from Phase 3 Trials at American Psychiatric Association (APA) Annual Meeting. |
|
|
May 4, 2012 |
735 |
| Sulpiride and melatonin decrease tinnitus perception modulating the auditolimbic dopaminergic pathway. |
|
Brief article |
May 1, 2012 |
274 |
| Pharmacotherapy for posttraumatic stress disorder: review with clinical applications. |
Jeffreys, Matthew; Capehart, Bruce; Friedman, Matthew J. |
Report |
May 1, 2012 |
8871 |
| Dr. Reddy's Announces the Launch of Olanzapine Tablets. |
|
|
Apr 24, 2012 |
453 |
| Johnson & Johnson fined $1.1B in Risperdal case. |
|
|
Apr 16, 2012 |
236 |
| Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats. |
Hritcu, Lucian; Cioanca, Oana; Hancianu, Monica |
Report |
Apr 15, 2012 |
5685 |
| Warnings over antipsychotic drugs. |
|
|
Apr 7, 2012 |
181 |
| Monitoring of dementia patients inadequate. |
Tucker, Miriam E. |
|
Apr 1, 2012 |
883 |
| Lithium reduces use of antipsychotics in bipolar. |
Brunk, Doug |
Clinical report |
Apr 1, 2012 |
1050 |
| Five factors flag antipsychotic prescribing for teens. |
Brunk, Doug |
Clinical report |
Apr 1, 2012 |
1180 |
| April 2012 - psychiatry: CPD questionnaires must be completed online via www.cpdjournals.co.za after submission you can check the answers and print your certificate. |
|
|
Apr 1, 2012 |
651 |
| Israel,United Kingdom,United States : Mylan and Teva unveil generic versions of antipsychotic Seroquel. |
|
|
Mar 31, 2012 |
101 |
| US District Court Finds SEROQUEL XR Formulation Patent Valid and Infringed. |
|
|
Mar 29, 2012 |
424 |
| XTL Biopharmaceuticals Reports Full-Year 2011 Results. |
|
Financial report |
Mar 29, 2012 |
894 |
| Mylan Launches Generic Version of Seroquel[R] Tablets, 25 mg. |
|
|
Mar 28, 2012 |
413 |
| Teva Announces Launch of Generic Seroquel[R] in the United States. |
|
|
Mar 28, 2012 |
690 |
| Dr. Reddy's Announces the Launch of Ziprasidone Hydrochloride Capsules. |
|
|
Mar 3, 2012 |
396 |
| Haloperidol raises risk of death for elderly. |
Sullivan, Michele G. |
|
Mar 1, 2012 |
524 |
| Alternatives perceived as ineffective. |
|
|
Mar 1, 2012 |
248 |
| Three key antipsychotics lose patent protection: state medicaid programs, patients to save as major atypical meds "go generic". |
Albright, Brian |
|
Mar 1, 2012 |
1494 |
| Forest Laboratories, Inc. and Gedeon Richter Plc. Announce Results from Two Positive Phase III Trials with the Investigational Antipsychotic Cariprazine for the Treatment of Schizophrenia. |
|
|
Feb 28, 2012 |
1435 |
| Anti-psychotic drugs could increase patients' death risk; RESEARCH CALL OVER FEARS FOR DEMENTIA SUFFERERS. |
|
|
Feb 28, 2012 |
664 |
| Dementia 'chemical cosh' risk warnings. |
|
|
Feb 27, 2012 |
344 |
| 'Chemical cosh' drug doubles death risk in dementia patients. |
|
|
Feb 24, 2012 |
342 |
| How antipsychotic medications lead to obesity and diabetes. |
|
|
Feb 2, 2012 |
546 |
| Spirituality may improve quality of life for schizophrenia. |
Mechcatie, Elizabeth |
|
Feb 1, 2012 |
475 |
| Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of Generic Versions Will Limit Commercial Opportunities for Pipeline Molecules. |
|
|
Jan 19, 2012 |
2944 |
| Fish & Richardson Attorneys Tom Melsheimer, Tommy Jacks Help Whistleblower, State of Texas Earn Historic Settlement in Lawsuit Over Risperdal Medication. |
|
|
Jan 19, 2012 |
501 |
| FDA panel recommends loxapine for approval: from a meeting of the FDA's Psychopharmacologic Drugs Advisory Committee. |
Mechcatie, Elizabeth |
|
Jan 1, 2012 |
1047 |
| Best practices in: the treatment of adults with schizophrenia: managing schizophrenia and overall health. |
Mattingly, Gregory W. |
|
Jan 1, 2012 |
1793 |
| Treating psychosis: sometimes less is more. |
Steingard, Sandra |
|
Jan 1, 2012 |
1617 |
| Brain cell malfunction linked to schizophrenia. |
|
|
Dec 29, 2011 |
516 |
| Research and Markets: Geodon - Analysis and Forecasts from 2002 to 2017. |
|
|
Dec 21, 2011 |
418 |
| Addict in pain pills switch. |
|
|
Dec 3, 2011 |
154 |
| Clinical handbook of psychotropic drugs, 19th rev. ed. |
|
Book review |
Dec 1, 2011 |
207 |
| Long-term administration of artesunate induces reproductive toxicity in male rats. |
Olumide, Stephen Akinsomisoye; Raji, Yinusa |
Report |
Dec 1, 2011 |
6687 |
| Research and Markets: Seroquel - Analysis and Estimates from 2002 to 2020 - The Report Includes Information on the Schizophrenia Market. |
|
Report |
Nov 30, 2011 |
419 |
| New Drug Application for Otsuka's Once-Monthly Aripiprazole Depot Formulation for Maintenance Treatment of Adult Patients with Schizophrenia Accepted for Review by the U.S. Food and Drug Administration. |
|
|
Nov 22, 2011 |
990 |
| BioLineRx Announces Receipt of Approval in India to Commence Phase II/III CLARITY Clinical Trial of BL-1020 for Treatment of Schizophrenia. |
|
|
Nov 22, 2011 |
1028 |
| Off-label use of atypicals proves minimally effective. |
Moon, Mary Ann |
|
Nov 1, 2011 |
483 |
| LATUDA[R] (lurasidone HCl) Shown to be Non-Inferior to SEROQUEL XR[R] (quetiapine fumarate XR) in Risk for Relapse in a 12-Month, Double-Blind Extension Study of Adult Patients with Schizophrenia. |
|
Clinical report |
Oct 27, 2011 |
3100 |
| Driven by Invega Sustenna, Aripiprazole Depot and Iloperidone Depot, Sales of the Atypical Depot Drug Class Will Nearly Double to $1.6 Billion in 2020 in the Schizophrenia Therapy Market. |
|
|
Oct 18, 2011 |
590 |
| Man charged with possessing 20,000 pills. |
|
|
Oct 17, 2011 |
198 |
| Off-label antipsychotics minimally effective. |
Moon, Mary Ann |
|
Oct 15, 2011 |
226 |
| Forest Laboratories, Inc. and Gedeon Richter Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder. |
|
|
Oct 5, 2011 |
993 |
| AstraZeneca Enters Into a Settlement Agreement with Handa Pharmaceuticals regarding U.S. SEROQUEL XR[R] Patent Litigation. |
|
|
Sep 29, 2011 |
1256 |
| The Bipolar Disorder Drug Market Will Decline from $6.5 Billion in 2010 to $4 Billion in 2020, Owing Largely to Increasing Generic Competition within the Atypical Antipsychotic Drug Class. |
|
|
Sep 28, 2011 |
547 |
| BioLineRx to Present Data from the Successfully Completed Phase IIb Trial of BL-1020 at European Conference on Schizophrenia Research. |
|
Conference news |
Sep 27, 2011 |
747 |
| Man is charged with drug 'contamination'. |
|
|
Sep 26, 2011 |
112 |
| Monday, 26 September 2011 THEPROFESSIONALS; Ensuring that patients get right prescription for anti-psychotic drugs Dr Jane Harrison explains how the latest phase of 1,000 Lives Plus work on the appropriate use of anti-psychotic drugs will benefit patients. |
|
|
Sep 26, 2011 |
615 |
| Arrest over contaminated Nurofen. |
|
|
Sep 24, 2011 |
142 |
| Laughter therapy as effective as anti-psychotic drugs in treating dementia. |
|
|
Sep 22, 2011 |
229 |
| Groups back forcing meds. |
Correa, Frances |
Brief article |
Sep 1, 2011 |
158 |
| Warning over Nurofen drug mix-up. |
|
|
Aug 30, 2011 |
278 |
| Cop hunt over pills. |
|
|
Aug 28, 2011 |
118 |
| CHEMISTS TO OPEN ALL NUROFEN PLUS. |
|
|
Aug 27, 2011 |
168 |
| CHEMISTS TO OPEN ALL NUROFEN PLUS. |
|
|
Aug 27, 2011 |
168 |
| 250,000 PACKS OF NUROFEN RECALLED; Pills sabotage confirmed. |
|
|
Aug 27, 2011 |
353 |
| 250,000 PACKS OF NUROFEN RECALLED; Pills sabotage confirmed. |
|
|
Aug 27, 2011 |
360 |
| Warning over Nurofen Plus packs containing wrong drugs. |
|
|
Aug 27, 2011 |
110 |
| Sabotage suspected painkiller mix-up; & UK WORLD. |
|
|
Aug 27, 2011 |
158 |
| Warning over Nurofen drug mix-up. |
|
|
Aug 27, 2011 |
278 |
| BLUNDER DRUGS; 500,000 powerful anti-psychotic pills in packets of Nurofen Plus sold in UK. |
|
|
Aug 26, 2011 |
553 |
| Warning over Nurofen drug mix-up. |
|
|
Aug 26, 2011 |
278 |
| Nurofen warning after batch mix-up; Anti-psychotic drugs may be in packets. |
|
|
Aug 26, 2011 |
461 |
| Warning of mix-up in pill packets. |
|
|
Aug 26, 2011 |
225 |
| Residential treatment for homeless female veterans with psychiatric and substance use disorders: effect on 1-year clinical outcomes. |
Harpaz-Rotem, Ilan; Rosenheck, Robert A.; Desai, Rani |
Report |
Aug 1, 2011 |
5662 |
| GRAN FORCED TO WAIT FOR DEMENTIA DRUGS; Family fury at seven month delay. |
|
|
Jul 30, 2011 |
439 |
| Antipsychotics Treatment Market Worth $24.2 bn; Accounts for 34% of CNS Drugs Sector: companiesandmarkets.com. |
|
|
Jul 29, 2011 |
442 |
| When Compared to Other Atypical Antipsychotics, Fewer Schizophrenia Patients Who Take Zyprexa in the First Line Progress to a Second-Line Therapy within a Year. |
|
|
Jul 27, 2011 |
511 |
| European Medicines Agency Accepts Vanda Pharmaceuticals Inc.'s Marketing Authorization Application For Oral Iloperidone Tablets. |
|
|
Jul 26, 2011 |
1017 |
| More Generalized Anxiety Disorder Patients Switch from Branded Antidepressants to Atypical Antipsychotics than Between Antidepressant Brands. |
|
|
Jul 21, 2011 |
528 |
| Offensive odor prompts recall of two risperidone lots. |
Mechcatie, Elizabeth |
|
Jul 1, 2011 |
383 |
| The new wave of SGAs: will high hopes for three new antipsychotics translate into better outcomes? |
Glazer, William M. |
|
Jul 1, 2011 |
1467 |
| The Majority of Therapies for the Treatment of Bipolar Disorder Are Taken by Bipolar Patients for at Least Three Months before Adding or Switching to a New Therapy. |
|
|
Jun 30, 2011 |
590 |
| BioLineRx Announces First Patient Enrolled in Phase II/III CLARITY Clinical Trial for BL-1020, a First in Class GABA-Enhanced Antipsychotic Treatment for Schizophrenia. |
|
Clinical report |
Jun 28, 2011 |
944 |
| Rule Will Prescribe Fewer Potent Drugs to Kids. |
|
|
Jun 22, 2011 |
388 |
| J&J Recalls 16,000 bottles of Antipsychotic Drug. |
|
|
Jun 18, 2011 |
205 |
| Quality of life after electroconvulsive therapy in persons with treatment resistant schizophrenia. |
Garg, Rohit; Chavan, B.S.; Arun, Priti |
Report |
Jun 1, 2011 |
2292 |
| Neuroleptic malignant syndrome in adolescents: four probable cases in the Western Cape. |
Henderson, Terri |
Report |
Jun 1, 2011 |
1823 |
| Aripiprazole-induced enuresis in a child with autistic disorder/Otizm tanili bir cocukta aripiprazole bacli enurezis. |
Bozkurt, Hasan; Abali, Osman |
Case study |
Jun 1, 2011 |
1556 |
| Antipsychotics in elders eyed. |
Anderson, Jane |
|
Jun 1, 2011 |
144 |
| D-Pharm Signs Deal With Jiangsu NHWA Pharmaceutical for Development and Commercialization of DP-VPA in China. |
|
|
May 31, 2011 |
672 |
| Former police officer accuses NHS over care. |
|
|
May 18, 2011 |
452 |
| EnVivo Announces Positive Phase 2b Clinical Data in Schizophrenia: EVP-6124 Meets Primary Endpoint with Statistically Significant Improvement in Cognition and Multiple Secondary Endpoints for Improvement in Function and Impact on Negative Symptoms. |
|
|
May 17, 2011 |
1071 |
| New trend emerging in borderline treatment. |
Boschert, Sherry |
|
May 1, 2011 |
711 |
| Antipsychotics and pregnancy. |
Cohen, Lee |
|
May 1, 2011 |
1057 |
| INTELLIPHARMACEUTICS FILES ANDA FOR GENERIC SEROQUEL XR. |
|
|
Apr 27, 2011 |
307 |
| INVEGA Approved as Treatment for Schizophrenia in Adolescents. |
|
|
Apr 11, 2011 |
2320 |
| Let metabolic effects drive antipsychotic drug choice. |
Zoler, Mitchel L. |
|
Apr 1, 2011 |
441 |
| Mitigating risks in antipsychotic prescribing: as tardive dyskinesia research continues, wise presenters are taking careful progress notes. |
Glazer, William M. |
|
Apr 1, 2011 |
1371 |
| Risperdal(R) Consta(R) Associated With Lower Risk of Hospitalisation Compared to Treatment With Other Antipsychotics in Patients With Schizophrenia. |
|
Clinical report |
Mar 25, 2011 |
1584 |
| Antipsychotics and fetal risks. |
|
|
Mar 15, 2011 |
216 |
| Elderly get fewer antipsychotics. |
|
|
Mar 15, 2011 |
133 |
| European Commission Approves XEPLION(R) for Treatment of Schizophrenia. |
|
|
Mar 9, 2011 |
1917 |
| Habit reversal training can bring end to tics: treatment sometimes works as a 'useful adjunct' to drug therapy and can be 'good place to start.'. |
Otto, M. Alexander |
Report |
Mar 1, 2011 |
816 |
| Antipsychotics and kids: proactive follow-up is key. |
Helwick, Caroline |
|
Mar 1, 2011 |
720 |
| Sexual side effects caused by psychotropic medications/Psikiyatrik ilac tedavilerine bagli cinsel islev bozukluklari. |
Yilmazer, Evrim Ebru; Guler, Julide |
Report |
Mar 1, 2011 |
6472 |
| The intersexual differences of sexual functions and prolactine levels in schizophrenia patients under antipsychotic medication/Antipsikotik tedavi uygulanan sizofreni hastalarinda prolaktin duzeyleri ve cinsel islevlerin cinsiyetlere gore karsilastirilmasi. |
Dogu, Basri; Kocabiyik, Ahmet; Karson, Fahri; Citak, Serhat; Incesu, Cem |
Report |
Mar 1, 2011 |
2929 |
| Forest Laboratories, Inc. and Gedeon Richter Plc Announce Results from a Phase II Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder. |
|
|
Feb 28, 2011 |
780 |
| ABILIFY[R] (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate. |
|
|
Feb 17, 2011 |
3043 |
| Antipsychotics for schizophrenia linked to subtle loss in brain volume. |
|
|
Feb 8, 2011 |
294 |
| Once-Daily Latuda[R] (lurasidone HCl) Now Available in Pharmacies Nationwide for the Treatment of Patients with Schizophrenia. |
|
|
Feb 3, 2011 |
2224 |
| New criteria issued for neuroleptic syndrome. |
Mahoney, Diana |
Disease/Disorder overview |
Feb 1, 2011 |
504 |
| INVEGA(R) Approved as First and Only Antipsychotic Treatment for Schizoaffective Disorder in the European Union. |
|
|
Jan 4, 2011 |
1262 |
| Atypicals, rTMS weighed for resistant anorexia nervosa. |
Wendling, Patrice |
|
Jan 1, 2011 |
878 |
| Commentary: an examination of the public justifications for the expansion of Canadian naturopaths' scope of practice. |
Murdoch, Blake; Hyde-Lay, Robyn; Caulfield, Timothy |
|
Jan 1, 2011 |
7984 |
| Research and Markets: Pipeline and Commercial Insight: Schizophrenia - Opportunity remains beyond positive symptoms. |
|
|
Dec 22, 2010 |
445 |
| Latuda[R] (lurasidone HCl) Significantly Improves Symptoms of Schizophrenia in Fifth Positive Placebo-Controlled Study. |
|
|
Dec 8, 2010 |
2967 |
| Settling in: N.H. nets $1.3m in pharma cases. |
Kibbe, Cindy |
Brief article |
Dec 3, 2010 |
236 |
| The relationship of akathisia with psychiatric symptoms, suicidality and other movement disorders in patients on antipsychotic treatment/Antipsikotik kullanan hastalarda akatizinin psikiyatrik belirtiler, intihar egilimi ve diger hareket bozukluklari ile iliskisi. |
Baskak, Bora; Yolac-Yarpuz, Asli; Devrimci-Ozguven, Halise; Atbasoglu, Cem |
Report |
Dec 1, 2010 |
5384 |
| Bilateral temporomandibular joint dislocation associated with use of anti-psychotic drug/Antipsikotik kullanimina bagli bilateral temporomandibuler eklem dislokasyonu. |
Annagur, Bilge Burcak; Tamam, Lut |
Report |
Dec 1, 2010 |
1193 |
| J&J wins new trial in WV drug lawsuit. |
|
|
Nov 30, 2010 |
322 |
| Cyrenaic Pharmaceuticals Reports Improvement of Negative Symptoms and Cognition in Schizophrenia Patients Treated with CYR-101. |
|
|
Nov 30, 2010 |
783 |
| New Research First to Reveal Healthcare Pricing Trends: Abilify Tops List for Savings Opportunities; Walmart, Target Show Widest Cost Discrepancies. |
|
|
Nov 22, 2010 |
1143 |
| Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA SUSTENNA. |
|
Clinical report |
Nov 19, 2010 |
1750 |
| Alkermes Presents Promising Preclinical Data on ALKS 33 for Multiple Disease Indications at Annual Meeting of the Society for Neuroscience. |
|
|
Nov 17, 2010 |
971 |
| Otsuka Prevails in U.S. Abilify(R) Patent Litigation. |
|
|
Nov 16, 2010 |
356 |
| First-Line Use of Abilify Has More Than Doubled Over the Past Year for the Treatment of Newly-Diagnosed Patients in Bipolar Disorder. |
|
|
Nov 16, 2010 |
771 |
| Otsuka Holdings to be listed on TSE on Dec. 15. |
|
|
Nov 15, 2010 |
129 |
| Lurasidone gets nod based on short-term data. |
Mechcatie, Elizabeth |
|
Nov 1, 2010 |
436 |
| FDA Roundup: Sunovion Pharmaceuticals Inc. |
|
|
Nov 1, 2010 |
620 |
| Dementia drug could be 'within our grasp', say Oz scientists. |
|
|
Oct 29, 2010 |
359 |
| FDA Approves Latuda to Treat Schizophrenia in Adults. |
|
|
Oct 28, 2010 |
503 |
| FDA Approves Once-Daily LATUDA[R] (lurasidone HCL) for the Treatment of Patients with Schizophrenia. |
|
|
Oct 28, 2010 |
2200 |
| Over the Next Three Years, Abilify and Seroquel XR Will Be the Fastest-Growing Drugs by Prescriptions for the Treatment of Major Depression. |
|
|
Oct 21, 2010 |
741 |
| Dopamine model could aid treatment of schizophrenia, drug addiction. |
|
|
Oct 21, 2010 |
278 |
| Johnson & Johnson (New Brunswick NJ) lost a huge jury verdict in Louisiana for making misleading claims about the safety of the company's Risperdal antipsychotic drug. |
|
|
Oct 18, 2010 |
320 |
| Link tightens between antipsychotics and VTE: association strongest in patients who started an antipsychotic in past 3 months. |
Wachter, Kerri |
|
Oct 15, 2010 |
1537 |
| Dementia drugs U-turn; New hope for sufferers of cruel disease. |
|
|
Oct 7, 2010 |
867 |
| UK study links antipsychotic drugs to clot risk. |
|
|
Oct 5, 2010 |
391 |
| Study finds frequent switching of antipsychotics. |
Helwick, Caroline |
|
Oct 1, 2010 |
557 |
| Antipsychotic use tied to venous thromboembolism risk. |
Wachter, Kerri |
Clinical report |
Oct 1, 2010 |
887 |
| The future of cognitive remediation training in older adults. |
Vance, David E.; Keltner, Norman L.; McGuinness, Teena; Umlauf, Mary Grace; Yuan, Yih-Ying |
Report |
Oct 1, 2010 |
7936 |
| ANTI-PSYCHOTIC drugs could increase [...]. |
|
|
Sep 27, 2010 |
205 |
| Antipsychotic drugs can cause pneumonia in the elderly. |
|
|
Sep 22, 2010 |
212 |
| Eli Lilly gets reversal of ruling granting class-action status for Zyprexa lawsuit. |
|
Brief article |
Sep 21, 2010 |
286 |
| FDA Approves NDA That Includes Psychiatric Data Collected by Centralized Raters. |
|
|
Sep 14, 2010 |
822 |
| Questions loom over use of Seroquel to treat PTSD, insomnia in veterans. |
|
|
Sep 7, 2010 |
875 |
| AstraZeneca given more time to settle 6,000 Seroquel lawsuits. |
|
|
Sep 7, 2010 |
529 |
| Aripiprazole and neuroleptic malignant syndrome in an adolescent patient: a case report /Ergen hastada aripiprazole bagli noroleptik malign sendrom: bir olgu sunumu. |
Kamisli, Ozden; Ozcan, Ozlem; Kaplan, Yuksel; Ozcan, Cemal |
Case study |
Sep 1, 2010 |
1636 |
| Practical psychopharmacology: consider carcinogenicity of psychotropics. |
Bates, Betsy |
|
Sep 1, 2010 |
1028 |
| The quest for the correct dose: recent efforts shed light on antipsychotic dosing, but find much work is left to be done. |
Glazer, William M. |
|
Sep 1, 2010 |
1279 |
| Forest Laboratories, Inc. and Gedeon Richter Plc Announce Results from a Phase II Study of Cariprazine for the Treatment of Bipolar Depression. |
|
|
Aug 30, 2010 |
773 |
| Through 2019, Increased Generic Erosion of Key Agents Such as Lamictal and Depakote/Depakote ER Will Cause a Precipitous $2.3 Billion Decline in the Bipolar Disorder Drug Market. |
|
|
Aug 25, 2010 |
614 |
| SureGene and the Medco Research Institute(TM) Enter a Collaboration to Evaluate the Ability of Genetic Biomarkers to Enhance Drug Selection for Serious Mental Health Illnesses. |
|
|
Aug 24, 2010 |
1288 |
| Astrazeneca Plc. |
|
|
Aug 16, 2010 |
270 |
| Owing to Generic Erosion of Key Agents Such as Effexor XR, Cymbalta/Xeristar, Cipralex/Seroplex and Lexapro, the Unipolar Depression Drug Market Will Decrease by Nearly 10 Percent in 2019. |
|
|
Aug 11, 2010 |
677 |
| MONEY BRIEFS. |
|
|
Aug 10, 2010 |
312 |
| Drug studies funded by industry are more likely to yield positive news. |
|
|
Aug 10, 2010 |
313 |
| AstraZeneca will keep Seroquel settlement terms confidential. |
|
Brief article |
Aug 10, 2010 |
260 |
| AstraZeneca Announces Agreements in Principle in SEROQUEL Product Liability Litigation. |
|
|
Aug 9, 2010 |
374 |
| After Peaking at $6.3 Billion in 2011, Generic Erosion of Atypical Antipsychotics Will Cause the Schizophrenia Drug Market to Decline to $5.2 Billion in 2019. |
|
|
Aug 5, 2010 |
700 |
| Drug Trials Funded by Industry Are More Likely to Publish Favorable Results. |
|
|
Aug 2, 2010 |
990 |
| New data blur typical-atypical drug distinctions. |
|
|
Aug 1, 2010 |
1280 |
| Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia. |
|
|
Jul 29, 2010 |
1547 |
| AstraZeneca to pay $2 million to settle Seroquel suits. |
|
|
Jul 27, 2010 |
520 |
| Medical stock spotlight: Cypress BioPharma Inc. |
|
|
Jul 26, 2010 |
800 |
| For children on antipsychotics, metabolic changes occur rapidly. |
Bates, Betsy |
|
Jul 1, 2010 |
1254 |
| Differential diagnosis of borderline personality disorder from bipolar disorder. |
Hatchett, Gregory T. |
|
Jul 1, 2010 |
7663 |
| Judge dismisses Risperdal suit against J&J. |
|
Brief article |
Jun 29, 2010 |
202 |
| Autistic children prescribed medicine for mental illness; DRUGS ALSO USED TO TREAT ADHD AND OTHER CONDITIONS. |
|
|
Jun 28, 2010 |
869 |
| Committee for Medicinal Products for Human Use (CHMP) Issues Opinion on European Regulatory Filing for Merck's Atypical Antipsychotic Medication SYCREST[R] (asenapine). |
|
|
Jun 25, 2010 |
12118 |
| Cephalon Provides Clinical Update on Phase II Study of NUVIGIL as an Adjunctive Therapy in Adults with Schizophrenia. |
|
|
Jun 2, 2010 |
1020 |
| 'Think outside the box' in treating anorexia. |
Wendling, Patrice |
|
Jun 1, 2010 |
979 |
| J&J unit pleads guilty to improper Topamax marketing. |
|
|
Jun 1, 2010 |
491 |
| Registry for atypical antipsychotics. |
Mechcatie, Elizabeth |
|
Jun 1, 2010 |
202 |
| Fred A. Baughman Jr., MD Announces: Vets' Deaths Are Not Suicides or 'Overdoses' but Sudden Cardiac Deaths Due to Prescription Antipsychotics and Antidepressants. |
|
|
May 24, 2010 |
1046 |
| Schizophrenia drugs turn up volume of brain's key signaling system. |
|
|
May 15, 2010 |
257 |
| New Study Finds Off-Label Use of Atypical Antipsychotics Increases Risk of Diabetes Among the Elderly. |
|
|
May 13, 2010 |
998 |
| 30% of Patients Seen by Primary Care Physicians Suffer From Depression. |
|
|
May 5, 2010 |
549 |
| AstraZeneca to pay $520 million for Seroquel promotion. |
|
Brief article |
May 5, 2010 |
109 |
| Joseph Biederman's comeuppance: a pharmaceutical psychiatrist is brought up short. |
Thompson, Jenny |
|
May 1, 2010 |
571 |
| Anticonvulsant warning led to decreased use. |
Guilford-Blake, Roxanna |
|
May 1, 2010 |
604 |
| Antipsychotic indications often not charted. |
Boschert, Sherry |
Brief article |
May 1, 2010 |
146 |
| Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing. |
|
|
Apr 27, 2010 |
1470 |
| Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing. |
|
|
Apr 27, 2010 |
1586 |
| Research and Markets: Disease and Therapy Review: Schizophrenia. |
|
|
Apr 15, 2010 |
280 |
| THE use of antipsychotic drugs [...]. |
|
|
Apr 12, 2010 |
200 |
| Nicotine withdrawal causes dangerous agitation in intensive care patients. |
|
|
Apr 11, 2010 |
229 |
| New drugs approved in 2009. |
Sears, Erin; Brooks, Sarah |
|
Apr 1, 2010 |
7236 |
| Where's the evidence? |
Selig, John |
|
Apr 1, 2010 |
873 |
| Drugs, pregnancy, and lactation: drugs approved in 2009. |
Briggs, Gerald G. |
|
Apr 1, 2010 |
1305 |
| Data flag risks of anticonvulsants in dementia. |
Guilford Blake, Roxanna |
|
Apr 1, 2010 |
708 |
| Zyprexa among stolen rugs. |
Auit, Alicia |
|
Apr 1, 2010 |
112 |
| New onset epilepsy following unintentional durotomy in a patient on anti-psychiatric medication. |
West, M.; Prasad, P.S.V.; Ampat, G. |
Clinical report |
Apr 1, 2010 |
1147 |
| Jury rules for AstraZeneca in Seroquel trial. |
|
|
Mar 23, 2010 |
517 |
| Killer laughed as he plunged to his death; Schizophrenic stopped taking medication. |
|
|
Mar 19, 2010 |
663 |
| Reportlinker Adds Disease and Therapy Review: Schizophrenia. |
|
|
Mar 18, 2010 |
631 |
| Johnson & Johnson (New Brunswick NJ) made plans to reach $302 million in geriatric sales for its antipsychotic Risperdal just months after federal regulators said the company falsely claimed the drug was safe and effective with the elderly, according to internal documents. The U.S. Food and Drug Administration. |
|
|
Mar 15, 2010 |
316 |
| Antipsychotic polypharmacy in schizophrenic inpatients/Yatan sizofreni hastalarinda coklu antipsikotik kullanimi. |
Ozalmete, Ozlem Albayrak; Ceylan, Mehmet Emin; Ozalmete, Onur; Sevim, Meltem Efe |
Report |
Mar 1, 2010 |
4176 |
| Antipsychotics and kids: data mostly reassuring. |
Correll, Christoph U. |
|
Mar 1, 2010 |
1074 |
| Focus on metabolic therapy in schizophrenia. |
Boschert, Sherry |
|
Mar 1, 2010 |
615 |
| Emerging Oral Atypical Antipsychotics Will Garner Only Limited Uptake in the Schizophrenia Drug Market. |
|
|
Feb 23, 2010 |
643 |
| State settles suit of Eli Lilly over Zyprexa for $18.5M. |
Paddack, Bill |
|
Feb 22, 2010 |
205 |
| Lilly revises Zyprexa label to warn about weight gain and hyperlipidemia in adolescents. |
|
Brief article |
Feb 9, 2010 |
197 |
| Mississippi settles Zyprexa suit for more than $18m. |
|
Brief article |
Feb 9, 2010 |
305 |
| AstraZeneca facing 26,000 lawsuits over Seroquel. |
|
|
Feb 9, 2010 |
495 |
| Alkermes Unveils Long-Acting Injectable Proprietary Platform for Treatment of Schizophrenia and Other CNS Disorders. |
|
|
Feb 4, 2010 |
917 |
| Antipsychotics' onset of action may show up after 2 weeks. |
Jancin, Bruce |
Clinical report |
Feb 1, 2010 |
790 |
| Metabolic testing with antipsychotics still lags. |
Boschert, Sherry |
|
Feb 1, 2010 |
739 |
| Early intervention could prevent schizophrenia before it starts. |
|
|
Jan 29, 2010 |
473 |
| /C O R R E C T I O N -- Decision Resources/. |
|
|
Jan 28, 2010 |
919 |
| J&J paid kickbacks to Omnicare, US says. Johnson & Johnson. |
|
|
Jan 18, 2010 |
333 |
| Johnson & Johnson accused of drug kickbacks. |
|
|
Jan 18, 2010 |
192 |
| Johnson & Johnson accused of drug kickbacks. |
|
|
Jan 17, 2010 |
192 |
| Zacks Analyst Blog Highlights: SUPERVALU Inc, Target, Novartis, Vanda Pharmaceuticals and Eli Lilly. |
|
|
Jan 13, 2010 |
955 |
| Metabolic monitoring in patients taking SGAs remains poor, research shows. |
|
|
Jan 13, 2010 |
1028 |
| CA1 activity flags path of schizophrenia. |
Matthews, Renee |
Clinical report |
Jan 1, 2010 |
745 |
| Relapses seen after stopping antipsychotics. |
Jancin, Bruce |
Clinical report |
Jan 1, 2010 |
344 |
| Side effects vary by diagnosis. |
Jancin, Bruce |
Brief article |
Jan 1, 2010 |
136 |
| Zyprexa Still a Top Seller. |
Ault, Alicia |
|
Jan 1, 2010 |
104 |
| Pharmacogenomic potential of psychiatric medications and CYP2D6. |
Foley, Kevin F. |
|
Jan 1, 2010 |
2350 |
| In the pipeline: non-stimulant ADHD MEDS: stimulant side effects drive development of alternative medications. |
Glazer, William M. |
Report |
Jan 1, 2010 |
1170 |
| Failures of feedback: rush hour along the highway to obesity. |
Gade, Wayne; Gade, Jean; Collins, Melissa; Schmit, Jessica; Schupp, Nicole |
Report |
Jan 1, 2010 |
5663 |
| FDA panel has concerns about child weight gain with Abilify. |
|
Brief article |
Dec 22, 2009 |
114 |
| New biosensors show how drugs used to treat schizophrenia work. |
|
|
Dec 14, 2009 |
276 |
| LILLY (ELI) & COMPANY - Regulatory Approval Lilly's ZYPREXA(R) RELPREVV(TM). |
|
|
Dec 14, 2009 |
1858 |
| LILLY (ELI) & COMPANY - FDA Approves Lilly Zyprexa 2 Adolescent Indications. |
|
|
Dec 7, 2009 |
1807 |
| Suicide risk in schizophrenia--a follow-up study after 20 years: Part 2: symptomatology and pharmacotherapy. |
Lippi, G.; Smit, D.J.; Jordaan, J.C.; Ross, J.L. |
Clinical report |
Dec 1, 2009 |
4735 |
| Adolescent-onset psychosis: a 2-year retrospective study of adolescents admitted to a general psychiatric unit. |
Paruk, S.; Ramlall, S.; Burns, J.K. |
Clinical report |
Dec 1, 2009 |
4392 |
| Is high dose risperidone an option for treatment-resistant Tourette syndrome?/Tedaviye direncli Tourette sendromunda yuksek doz risperidon bir secenek midir? |
Copur, Mazlum; Arpaci, Baki; Basgul, S. Senem |
Report |
Dec 1, 2009 |
2138 |
| Omnicare coughs up $98 million for kickbacks. |
|
|
Dec 1, 2009 |
577 |
| Parent training can help reduce behaviour problems in autistic kids. |
|
|
Nov 26, 2009 |
237 |
| Psychiatric meds for kids can bring on weight gain: antipsychotic drugs may create metabolic trade-offs. |
Seppa, Nathan |
Brief article |
Nov 21, 2009 |
207 |
| U.S. Food and Drug Administration Approves ABILIFY[R] (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years). |
|
|
Nov 20, 2009 |
2992 |
| Dementia drug linked to 1,800 deaths. |
|
|
Nov 16, 2009 |
308 |
| Dementia drug linked to 1,800 deaths. |
|
|
Nov 15, 2009 |
308 |
| Dementia drug linked to 1,800 deaths. |
|
|
Nov 14, 2009 |
308 |
| Dementia drug linked to 1,800 deaths. |
|
|
Nov 13, 2009 |
308 |
| Dementia drug linked to 1,800 deaths. |
|
|
Nov 12, 2009 |
308 |
| AstraZeneca pays $520 million to settle Seroquel cases. |
|
Brief article |
Nov 10, 2009 |
240 |
| Omnicare, Teva pay $112 million for kickbacks. |
|
Brief article |
Nov 10, 2009 |
220 |
|
